Myopia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 6 to 60 years old, regardless of gender; 2. Spherical equivalent refraction: either eye = -0.5D; 3. Distance exophoria =15 prism diopters, distance esophoria =10 prism diopters; 4. With normal thinking and language communication abilities, subjects and their guardians can abide by the relevant rules of the trial, with high compliance; 5. Subjective cooperation and participants or their guardians are able to sign a written informed consent form. A signed, dated informed consent form is required, indicating that the patient (or a legal representative) has been informed of all relevant information about the study.
Exclusion criteria
Exclusion criteria: Subjects who met any of the following criteria were excluded from this study. 1. There are active ocular infections, such as acute conjunctivitis, keratitis, scleritis, uveitis, iridocyclitis, endophthalmitis, etc. 2. Previous surgical history of ocular diseases other than refractive surgery, such as cataract phacoemulsification and intraocular lens implantation, trabeculectomy, vitrectomy, corneal transplantation, etc. 3. Presence of congenital eye diseases, such as congenital cataract, congenital glaucoma, retinopathy of prematurity, familial hereditary retinopathy, etc 4. The presence of progressive eye diseases, such as keratoconus, glaucoma, fundus hemorrhage, diabetic retinopathy, need to be treated with iridectomy, retinal laser photocoagulation, intraocular injection and other treatment interventions; 5. Very low birth weight infant, birth weight less than 1500g. 6. Patients with other systemic diseases that may affect the eyes, such as albinism, epilepsy, and rheumatic immune diseases 7. Patients with severe primary diseases such as liver, kidney, cardiovascular system diseases and mental disorders 8. Other circumstances deemed by the investigator to be inappropriate for trial participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anterior segment image;fundus image;ocular surface function examination;Refractive state; | — |
Secondary
| Measure | Time frame |
|---|---|
| tear fluid inflammatory cytokines; | — |
Countries
China
Contacts
Renji Hospital, Shanghai Jiao Tong University School of Medicine